Message from the Publisher


Message from the Publisher

Multimed Inc.



Current Oncology has made great strides over the years to improve the quality, success, and sustainability of our renowned journal. With the help of our dedicated team of editors and reviewers, we have increased the journal’s global impact and its readership levels, while continuing to attract and publish high-quality articles. Current Oncology ’s recognition and reach in the Canadian oncology community could not be possible without the commitment and dedication of its many authors. Additionally, many of the articles published in the journal are referenced by leading researchers and oncologists worldwide. Building on our collective efforts and furthering our reputation of publishing high quality papers, Current Oncology is calling for the submission of original clinical research and clinical trials articles. To help encourage submissions, Current Oncology will waive its standard author fees for all original clinical trials and clinical research articles submitted between 1 July and 31 December 2015.

Articles that contain information directly relevant to clinical oncology practice and that have clear potential for application to the current or future practice of cancer medicine are strongly encouraged. Topics can include research related to treatment, prevention, diagnostics, screening, or quality of life for patients. Articles on clinical research and clinical trials will undoubtedly play a key role in realizing our goal to have the journal indexed in medline , the premier bibliographic database of the U.S. National Library of Medicine. We are confident that, by broadening our catalogue of oncology articles, important research and studies will achieve greater visibility in the international oncology community.

We look forward to receiving your articles. Manuscripts can be submitted electronically through our online submission and peer review system at

For information about preparing your manuscript for submission, please visit the Information for Authors page at our Web site.


Starting with this June 2015 issue, we are pleased to introduce a new journal design. Its highlights include easier access to citation information for all articles, together with the prominent display of the corresponding author information on the first page. A new typeface reduces the overall page count and allows for the publication of more articles (print and online), thus lowering the article processing fee for authors. Finally, a more uniform look is achieved across all of our platforms, with the Current Oncology logo now appearing on all articles.

We hope that you enjoy the new look of Current Oncology !

Thank you for your continued support in keeping Current Oncology Canada’s premier oncology journal.

Correspondence to: Multimed Inc., Publisher, Current Oncology , 66 Martin Street, Milton, Ontario L9T 2R2. E-mail:

(Return to Top)

Current Oncology , VOLUME 22 , NUMBER 3 , June 2015

Copyright © 2019 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)